PROTHENA CORPORATION PLC
Last · —$8.37+0.01 (+0.12%)live · yahoo · 2h ago
Vol 266.4K ≈ 2.28M
MA10MA20MA50
Market cap$429.69M—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
Issuer
Legal namePROTHENA CORPORATION PLC
HQUnited States (US)
ListingUS PRTA
ISINIE00B91XRN20
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001559053
CIK0001559053
Websitewww.prothena.com
Employees67
AddressProthena Corp. Plc 77 Sir John Rogersons Quay 2, Dublin +353 1 236 2500
| Revenue | $32.2M |
|---|---|
| Net income | $17.9M |
| Free cash flow | $17.9M |
| Net margin | 55.4% |
| Return on equity | 9.2% |
Loading chart…
Upcoming earnings
THU.5NOV
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.38
Est. revenue
9.6M
Earnings transcripts
- Issuer webcast
Webcast
PROTHENA CORPORATION PLC
- Issuer webcast
Earnings Presentation
PROTHENA CORPORATION PLC
- Issuer webcast
Webcast
PROTHENA CORPORATION PLC
- Issuer webcast
(opens in new window)
PROTHENA CORPORATION PLC
- Issuer webcast
H.C. Wainwright Global Investment Conference (opens in new window) Webcast
PROTHENA CORPORATION PLC
- Issuer webcast
(opens in new window)
PROTHENA CORPORATION PLC
Documents
FormReporting forFiledFlags
—2026-12-31≈0
Showing 5 of 211 filings